P-118 - Embolization of a type II endoleak via octopus graft after TAAA repair (ID: 56591)

R. Müller-Wille, P. Heiss, C. Stroszczynski, W. Uller, P. Wiggermann, N. Zorger

Topic:

Embolotherapy (excluding oncology)

Session:

EP 2011 - Electronic Posters 2011 (478 presentations)

2009.1 - Interim analysis six-months results of the SUPER-SL study: multi-center prospective, randomized, two-arm clinical investigation of the Cordis S.M.A.R.T.™ CONTROL ™ Nitinol Stent System versus the Bard® Luminexx™ 6F vascular stent for the treatment of TASC (ID: 16222)

S. H. Duda, T. Zeller, G. Tepe, H. Krankenberg, K. L. Schulte, J. Tessarek, J. O. Balzer, N. Zorger, K. Amendt, D. Scheinert

Topic:

Vascular

Session:

FP 2009 - Late Breaking Abstracts (6 presentations)

P-4 - Percutaneous interventions in pediatric patients after liver transplantation (ID: 57150)

W. Uller, H. Gößmann, S. Schmid, S. Schleder, B. Knoppke, P. Heiss, H. J. Schlitt, C. Stroszczynski, N. Zorger

Topic:

Biliary intervention

Session:

EP 2011 - Electronic Posters 2011 (478 presentations)

1303.1 - Peripheral and visceral embolotherapy with ethylene vinyl alcohol copolymer (Onyx): incidence of non-target vessel embolization and ischemic complications (ID: 56311)

R. Müller-Wille, N. Zorger, P. Wiggermann, R. Forbrig, W. Uller, S. Schleder, C. Stroszczynski, P. Heiss

Topic:

Embolotherapy (excluding oncology)

Session:

FP 1303 - Embolotherapy (6 presentations)

1303.5 - Twelve-months results of a randomized multi-center head-to-head comparison of the S.M.A.R.T.™ CONTROL™ Nitinol Stent (Cordis®) with the Luminexx™ 6F Stent (Bard®) for the treatment of long TASC C and D superficial femoral artery lesions: the SUPER-SL stud (ID: 39187)

S. Duda, D. Scheinert, T. Zeller, G. Tepe, H. Krankenberg, K. L. Schulte, J. Tessarek, V. Khan, N. Zorger, K. Amendt

Topic:

Vascular

Session:

FP 1303 - Peripheral arterial interventions - Infra inguinal (6 presentations)